Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. The basal transcription machinery for RNA polymerase II
- Prof. H. T. Marc Timmers
-
2. The Myc transcription factor network
- Prof. Robert N. Eisenman
-
3. Role of polycomb proteins in gene transcription, stem cell and human diseases
- Prof. Luciano Di Croce
-
4. Heterochromatin, epigenetics and gene expression
- Prof. Joel C. Eissenberg
-
5. Histone dynamics, heritability and variants
- Dr. Genevieve Almouzni
-
6. Hox gene regulation in vertebrate hindbrain development
- Prof. Robb Krumlauf
-
7. Enhancer malfunction in cancer
- Dr. Ali Shilatifard
-
8. Maintaining the silenced state of master regulatory genes during development
- Prof. Robert Kingston
-
9. Genomic insights into gene regulation by cohesin
- Prof. Dale Dorsett
- Archived Lectures *These may not cover the latest advances in the field
-
11. DNA methylation
- Prof. Steve Jacobsen
-
12. Accessing and using ENCODE data
- Prof. Peggy Farnham
-
13. Visualization of transcription factor interactions in living cells
- Prof. Tom Kerppola
-
14. The beta-globin locus
- Dr. Ann Dean
Printable Handouts
Navigable Slide Index
- Introduction
- Myc - regulation and function
- Myc gene rearrangements in cancer
- Organization of Myc family proteins
- Myc transcription complexes
- Control of Myc levels
- Mxd family of transcriptional repressors
- Mxd1 SID domain
- Myc and Mxd - functional antagonists
- Myc-Max to Mxd1-Max switch during differentiation
- Myc and Mad regulate histones acetylation state
- An overview of the Myc-Max network
- The drosophila Max network
- Myc expression correlates with cell size
- Increased dMyc expression produces larger cells
- dMyc increases growth rate of cells
- dMnt inhibits cell growth, attenuates proliferation
- c-Myc expression and an increase in B cell size
- Cell growth and cell proliferation
- Drosophila and mammalian cells
- Myc-Max proposed transcriptional cascade (1)
- Myc-Max proposed transcriptional cascade (2)
- dMyc, dMax, dMnt binding to genomic loci
- Widespread binding to promoters containing E-box
- Myc-Max binding effects and target genes
- Functional classes of Myc-regulated genes
- Myc affects cell growth via RNA POL I, II and III
- Myc - roles and regulation in cellular metabolism
- A new suggested extended network for Myc action
- Myc transcriptional network overview
- Non-transcriptional activities of Myc
- Some open questions concerning Myc
- Slide citations
- Selected reviews and references
- Acknowledgements
Topics Covered
- Myc plays a broad role in cellular functions
- Deregulation of Myc is associated with many cancers
- Myc and Mxd proteins heterodimerize with Max, bind DNA, and activate or repress transcription through recruitment of co-regulator complexes that in turn influence chromatin modifications
- Myc family proteins are highly conserved and regulate cell growth by binding to many genes involved in translation and metabolism
- Myc also has functions unrelated to transcription
- Update talk: The MYC transcription factor network
- Update talk: Interactions of MYC with other cellular proteins
- Update talk: Topologically Associated Domains (TADs)
- Update talk: Transcriptional functions of MYC
- Update talk: Proximal MYC network
- Update talk: New approaches to inhibiting MYC activity
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Eisenman, R.N. (2023, January 31). The Myc transcription factor network [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/NNVI2726.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert N. Eisenman has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Update Available
The speaker addresses developments since the publication of the original talk. We recommend listening to the associated update as well as the lecture.
- Full lecture Duration: 47:03 min
- Update Duration: 15:59 min
A selection of talks on Cancer
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Bob Eisenman.
I'm in the division of Basic Sciences at the Fred Hutchinson Cancer Research Center.
In this lecture, I'm going to discuss the Myc transcription factor network.
The Myc network is comprised of a group of highly conserved proteins known
to play critical roles in the behavior of almost all normal cell types.
In addition, these factors are deeply involved in
the ideology of a wide range of human and other animal cancers.
In what follows, I will draw on the work from many laboratories,
including our own, in order to describe the components of the network,
their interactions and activities,
and what recent research is telling us about the manner in which
they influence normal and abnormal cellular functions.
0:43
The founding member of the Myc network
and the jumping off point for this lecture is Myc itself.
An important aspect of Myc is that
transcription of the Myc gene and the subsequent production of its encoded Myc protein,
is regulated by a large number of signal transduction pathways.
Indeed, most major cytokines,
growth factors and other mitogenic signals in
many different cell types use signaling cascades
that are known to stimulate gene transcription.
A few of these are listed at the top of the slide.
In many cases, induction of Myc transcription
is an immediate early response to these signaling pathways.
In other words, these pathways directly result in Myc transcription,
and do not require any intervening protein synthesis to do so.
In other cases, the induction of Myc occurs as an indirect response to signaling.
The important point in either case, is that Myc gene represents a central node
at which multiple mutagenic signals converge.
It follows then, that the levels of Myc RNA and protein
reflect the amount and duration of different signaling inputs.
Studies from many labs have shown that in
addition to its regulation by signal transduction pathways,
the abundance of Myc RNA and protein is highly controlled at many other levels.
These include transcriptional elongation,
export of Myc RNA from the nucleus,
stability of Myc RNA,
translational control of Myc messenger RNA,
and proteolysis of the Myc protein itself.
It would seem that cells have evolved
multiple mechanisms to keep tabs on the levels of Myc.
We know that in most normal proliferating cells,
as well as during normal embryonic development in many organisms,
Myc is involved in critical aspects of cell behavior, including growth,
metabolism, proliferation and the control of differentiation, and the apoptosis.
Importantly, however, in situations where Myc expression is deregulated,
and I will describe what I mean by this in a moment,
there is evidence of increased growth in proliferation, altered metabolism,
attenuated differentiation, increased apoptosis and genomic instability.
All of these events are closely associated with
the progression and maintenance of a tumor phenotype.